Clinical Trials Directory

Trials / Terminated

TerminatedNCT01262547

A New Micrografting Technique for Vitiligo

A Randomized Controlled Pilot Study to Examine the Use of Micrografting, Using a Novel Grafting Technique for the Repigmentation of Vitiligo

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study evaluates micrografting using a harvesting and grafting process that has been designed by Momelan Technologies. The overall concept is to harvest several small pieces of skin, each measuring about 1.75 mm in diameter from a normal pigmented area using a commercially available suction blister device, adhere them to a sterile elastomeric substrate and is then place it on a recipient area prepared by epidermal dermabrasion (removal of the epidermis).

Detailed description

Participants with vitiligo patches undergo removal of the epidermis of the affected vitiligo skin with dermabrasion. Several small pieces of pigmented skin (1.75mm) from the patient are taken from another area with the use of a suction blister device. The harvested pigmented skin is adhered to a sterile elastomeric substrate and placed on the previously dermabraded affected area. Originally the primary outcome was percentage of change in pigmentation with UV photos at 10 weeks in sites undergoing grafts compared to control sites. However, because we were unable to take UV photos, we had to revise our primary outcome.

Conditions

Interventions

TypeNameDescription
DEVICEDermabrasion-MicrograftingSeveral small pieces of skin, each measuring 1.75 mm in diameter will be harvested from a normal pigmented area using a commercially available suction blister device. This will be attached to a sterile elastomeric substrate and then placed on a recipient area prepared by epidermal dermabrasion (removal of the epidermis).
PROCEDUREDermabrasionOnly dermabrasion (removal of epidermis) alone will be done at baseline.

Timeline

Start date
2011-09-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2010-12-17
Last updated
2014-10-31
Results posted
2014-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01262547. Inclusion in this directory is not an endorsement.